EMO Biomedicine

EMO Biomedicine is Taiwan’s first CRO focused on cell-based assays and therapeutic cell-based products. It is accredited by the Taiwan Accreditation Foundation (TAF) for testing of biologics and has TFDA-certified facilities for manufacturing mesenchymal stem cell–based products. The company supports local and global clients with contract research, development, manufacturing, analytical testing, process development/validation services in compliance with international standards. It does not appear to have its own proprietary therapeutics in clinical trials but plays a pivotal role as an enabling partner in the biopharma ecosystem.